Phase I & II Formula
Natural health product licensed in Canada
- Other names
- Detoxification
- Licence holder
- Future Formulations Inc.
- NPN or DIN-HM
- 80057874
- Status
- Active licence
- Licence date
- 3 February 2015
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine C: up to 300 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 180 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Sélénium: up to 180 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 50 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitis vinifera Source : Vitis vinifera - Graine Extraction ratio : 4:1 Dry plant equivalent : 20 mg Potency : 95 % Oligomeric proanthocyanidins | 5 mg | Not calculated |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 33.5 mg AT | Not calculated |
| L-Méthionine Source : L-méthionine | 108.5 mg | Not calculated |
| Calcium Source : Glutarate de calcium | 30 mg | 180,000 µg |
| L-Glutathione Source : Glutathione | 10 mg | Not calculated |
| L-Carnitine Source : Fumarate de L-carnitine | 10 mg | Not calculated |
| Vitamine E Source : Succinate d'acide de d-alpha tocophéryle | 50 UI | Not calculated |
| Vitamine C Source : Vitamine C | 50 mg | 300,000 µg |
| Vitamine B12 Source : Vitamine B12 | 20 mcg | 120 µg |
| Folate Source : Folate | 100 mcg | Not calculated |
| Sélénium Source : Citrate de sélénium | 30 mcg | 180 µg |
| L-Sérine Source : L-sérine | 10 mg | Not calculated |
| Acide aminoacétique Source : Glycine | 30 mg | Not calculated |
| N-Acétyl-L-cystéine Source : N-Acétyl-L-cystéine | 30 mg | Not calculated |
| L-Glutamine Source : L-Glutamine | 30 mg | Not calculated |
| Acide L-glutamique Source : Acide glutamique | 30 mg | Not calculated |
| Acide (S)-2,5-diaminopentanoïque Source : L-Ornithine | 15 mg | Not calculated |
| Acide 2-aminoéthanesulfonique Source : Taurine | 30 mg | Not calculated |
| 2-(3,4-dihydroxyphényl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one Source : Quercétine | 5 mg | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 10 mg | Not calculated |
| Silybum marianum Source : Silybum marianum - Graine Extraction ratio : 4:1 Dry plant equivalent : 20 mg Potency : 80 % Silymarin | 5 mg | Not calculated |
Non-medicinal ingredients
Stéarate de magnésium, Concentré de protéine de riz, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 3 days |
Uses authorised in Canada
Text supplied in English because no French text is available.
Source of antioxidant for the maintenance of good health. A factor for the maintenance of good health. Helps to support liver function. Helps to support cardiovascular health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80057874
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.